Cromolyn sodium
USP/1150502 - United States Pharmacopeia (USP) Reference Standard
Synonym: Cromolyn sodium salt; Cromoglycate; Cromoglycic acid
CAS Number: 15826-37-6
Empirical Formula (Hill Notation): C23H14Na2O11
Molecular Weight: 512.33
MDL Number: MFCD00057744
Linear Formula: C23H14O11Na2
Product Type: Chemical
| API family | cromolyn |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C23H16O11.Na.H/c24-11( |
| InChI key | UXMUBZWVLQEMRB-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | [Na].OC(COc1cccc2OC(=CC(= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Cromolyn sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Cromolyn Sodium Ophthalmic Solution • Cromolyn Sodium Inhalation Solution • Cromolyn Sodium Nasal Solution • Cromolyn Sodium Oral Solution |
| Biochem/physiol Actions: | Cromolyn blocks the release of histamine and other pro-inflammatory mediators from mast cells. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Other Notes: | Sales restrictions may apply. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |


